Gynecology Products

A line of products designed to provide a gentle approach to the treatment of Inflammation and infections of the urinary tract, to prevent and treat problems of poor circulation, microcirculation, venous stasis and hemorrhoidal crisis, for the delicate Skin cleansing and intimate hygiene, and to provide an optimal Hydration and Protection of skin in pregnancy and not.













RSS American Journal of Obstetrics & Gynecology

  • AJOG GR Table of Contents August 1, 2024
  • Information for readers August 1, 2024
  • AJOG MFM Table of Contents August 1, 2024
  • Table of Contents August 1, 2024
  • SMFM Divider Page August 1, 2024
  • A United States stillbirth prevention bundle August 1, 2024
    The stillbirth rate in the United States is considerably higher than in many countries with similar resources.1–3 In 2021, the United States stillbirth (loss before birth at ≥20 weeks’ gestation) ratio was 5.73 per 1000 births or 1 in 175 pregnancies with 21,000 stillbirths occurring annually.3 For example, in 2021, the late stillbirth rate (>28 […]
    Robert M. Silver, Joanne L. Stone
  • Successful eradication of group B Streptococcus intraamniotic infection with antibiotics in preterm prelabor rupture of the membranes July 25, 2024
    Intraamniotic infection, a major cause of the preterm labor syndrome, is a risk factor for neonatal morbidity and mortality as well as long-term handicap.1 The frequency of intraamniotic infection in preterm prelabor rupture of the membranes (PPROM) is 40%.2 Common microorganisms found in the amniotic cavity of patients with PPROM include Sneathia species, Ureaplasma spp., […]
    Puntabut Warintaksa, Roberto Romero, Pisut Pongchaikul, Pornpun Vivithanaporn, Arun Meyyazhagan, Bo Hyun Yoon, Arunee Singsaneh, Piya Chaemsaithong
  • Corrigendum July 25, 2024
    The authors of the articles listed below regret that there have been instances where the terms progesterone and 17α-hydroxyprogesterone caproate (17-OHCP or 17P) have been used interchangeably. To clarify, the terminology in the following publications have been amended and the online versions are now corrected.
  • Introduction of a nationwide first-trimester anomaly scan in the Dutch national screening program July 25, 2024
    A significant proportion of major fetal structural anomalies can be detected in the first trimester by ultrasound examination. However, the test performance of the first-trimester anomaly scan (FTAS) performed in a low-risk population as part of a nationwide prenatal screening program is unknown. Potential benefits of the FTAS include early detection of fetal anomalies, providing […]
    Eline E.R. Lust, Kim Bronsgeest, Lidewij Henneman, Neeltje Crombag, Caterina M. Bilardo, Robert-Jan H. Galjaard, Esther Sikkel, Sanne van der Hout, Audrey Coumans, Ayten Elvan-Taşpınar, Attie T.J.I. Go, Sander Galjaard, Gwendolyn T.R. Manten, Eva Pajkrt, Liesbeth van Leeuwen, Monique C. Haak, Mireille N. Bekker
  • Zebras in a Snowstorm: Ultrasound guidance for differentiating placental mesenchymal dysplasia from hydatidiform mole. July 25, 2024
    Nicholas B. LOLLI, Amanda M. MCWHIRTER, Karen B. LESSER, Demaretta S. RUSH, Ahmed G. ABOUL-NASR, Lynn M. COPPOLA
  • Racial and ethnic disparities in reproductive medicine in the United States: A narrative review of contemporary high-quality evidence July 24, 2024
    There has been increasing debate around how or if race and ethnicity should be used in medical research—including the conceptualization of race as a biological entity, a social construct, or a proxy for racism. The objectives of this narrative review are to identify and synthesize reported racial and ethnic inequalities in obstetrics and gynecology (ob/gyn) […]
    Ayodele G. LEWIS, Divya K. SHAH, Regina LEONIS, John REES, Katharine F.B. CORREIA
  • Publication of the ARRIVE Trial and Changes in Early Term Induction of Labor July 24, 2024
    Taylor S. FRERET, Anjali J. KAIMAL, Alexander MELAMED, Mark A. CLAPP
  • The fibroid crisis in Black women: more work to be done! July 24, 2024
    Although prevalent among all women, uterine fibroids are uniquely pernicious in Black women, who experience significantly higher rates, with earlier onset and more complex disease. Epitomized by the biopsychosocial model, the root causes of these disparities in prevalence, symptoms, and outcomes are numerous and multifaceted, and they are at the intersection of biological constructs and […]
    Rachel Michel, Wanda K. Nicholson, Mostafa A. Borahay
  • HOT FLASHES AND SLEEP DISRUPTION IN A RANDOMIZED TRIAL IN MENOPAUSAL WOMEN July 20, 2024
    Hot flashes, common during menopause, affect up to 80% of Western menopausal women and are reported to contribute to sleep disturbances in midlife. Few prospective data are available to confirm the specific role of hot flashes in disrupting sleep in midlife women, however, or confirm whether changes in hot flashes in response to clinical therapies […]
    Mingzhuo PEI, Carolyn J. GIBSON, Michael SCHEMBRI, Harini RAGHUNATHAN, Deborah GRADY, Peter GANZ, Alison J. HUANG
  • Prevention of postpartum hemorrhage is essential for patients with placental diseases after hysteroscopic adhesiolysis July 18, 2024
    We read with interest the article published in May 2024 by Mortimer et al,1 which focused on pregnancy complications and neonatal outcomes of in vitro fertilization (IVF) pregnancies in patients treated for intrauterine adhesions (IUAs) by hysteroscopy. This retrospective study found that patients who underwent hysteroscopic adhesiolysis (HA) are at considerably increased risk of placental diseases, such […]
    Yongdan Ma, Jingmei Ma